Table 1.
CMC Cohort (n=167) | GCARS Cohort (n=770) | p-value* | |||
---|---|---|---|---|---|
n | % | n | % | ||
Patient Characteristics
| |||||
Age in years [median, (IQR)] | 7.8 | (4.2-12.3) | 5.4 | (2.9-9.0) | <0.0001 |
Male sex | 105 | 62.9 | 500 | 64.9 | 0.61 |
Race | <0.0001 | ||||
White | 138 | 82.6 | 254 | 33.0 | |
Black | 23 | 13.8 | 440 | 57.1 | |
Other | 6 | 3.6 | 76 | 9.8 | |
Hispanic Ethnicity | 2 | 1.2 | 25 | 3.3 | 0.15 |
Primary Insurer | <0.0001 | ||||
Private | 67 | 40.1 | 171 | 22.2 | |
Public | 100 | 59.9 | 599 | 77.8 | |
Secondary Insurer | 131 | 81.4 | |||
Caregiver Characteristics | |||||
Age in years[median, (IQR)] | 40 | (32-46) | 30 | (26-35) | <0.0001 |
Male sex | 24 | 14.4 | 81 | 10.5 | 0.15 |
Marital Status | <0.0001 | ||||
Single | 33 | 19.9 | 484 | 66.3 | |
Married | 98 | 59.0 | 209 | 28.6 | |
Separated | 14 | 8.4 | 34 | 4.7 | |
Divorced | 18 | 10.8 | 3 | 0.4 | |
Widowed | 3 | 1.8 | 0 | 0 | |
Clinical Characteristics (Patients in CMC Cohort) | |||||
Complex Chronic Conditions | |||||
Neurologic/Neuromuscular | 119 | 74.4 | |||
Congenital/Genetic defect | 113 | 70.6 | |||
Gastrointestinal | 109 | 68.1 | |||
Cardiovascular | 83 | 51.9 | |||
Respiratory | 77 | 48.1 | |||
Metabolic | 54 | 33.8 | |||
Renal | 53 | 33.1 | |||
Transplant/Miscellaneous | 46 | 28.8 | |||
Neonatal | 40 | 25.0 | |||
Hematology/Immunodeficiency | 29 | 18.1 | |||
Malignancy | 17 | 10.6 | |||
CCC count [median, (IQR)] | 5 | [3-6] | |||
Technology Dependence | 119 | 71.3 | |||
Gastrointestinal | 104 | 65.0 | |||
Miscellaneous | 46 | 28.8 | |||
Respiratory | 44 | 27.5 | |||
Neurologic/Neuromuscular | 18 | 11.3 | |||
Cardiovascular | 13 | 8.1 | |||
Renal | 14 | 8.8 | |||
Metabolic | 4 | 2.5 | |||
Number of Subspecialists [median, (IQR)] | 7 | [5-10] |
p-value assessing comparison between CMC and GCARS cohorts using Chi-square test for categorical variables and Wilcoxon Rank Sum test for continuous variables